Definium Therapeutics, Inc. (DFTX)
24.19
+0.71
(+3.02%)
USD |
NASDAQ |
May 29, 16:00
24.03
-0.16
(-0.66%)
After-Hours: 20:00
Definium Therapeutics Shareholders Equity (Quarterly) : 278.85M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.116M |
| CNBX Pharmaceuticals, Inc. | -2.534M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 386.80M |
| Fulcrum Therapeutics, Inc. | 333.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 401.29M |
| Total Liabilities (Quarterly) | 122.44M |
| Debt to Equity Ratio | 0.1462 |
| Current Ratio | 4.692 |
| Net Debt Paydown Yield | -0.19% |